Amundi’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.6M | Buy |
1,323,423
+644,665
| +95% | +$11M | 0.01% | 690 |
|
|
2025
Q1 | $10.1M | Buy |
678,758
+105,846
| +18% | +$1.57M | ﹤0.01% | 830 |
|
|
2024
Q4 | $12.3M | Sell |
572,912
-80,958
| -12% | -$1.74M | ﹤0.01% | 810 |
|
|
2024
Q3 | $11.5M | Sell |
653,870
-701
| -0.1% | -$12.3K | ﹤0.01% | 818 |
|
|
2024
Q2 | $11M | Buy |
654,571
+114,100
| +21% | +$1.92M | ﹤0.01% | 817 |
|
|
2024
Q1 | $6.91M | Buy |
540,471
+105,578
| +24% | +$1.35M | ﹤0.01% | 905 |
|
|
2023
Q4 | $4.96M | Sell |
434,893
-80,710
| -16% | -$920K | ﹤0.01% | 984 |
|
|
2023
Q3 | $4.47M | Buy |
515,603
+6,280
| +1% | +$54.4K | ﹤0.01% | 1005 |
|
|
2023
Q2 | $3.81M | Buy |
509,323
+58,430
| +13% | +$437K | ﹤0.01% | 1034 |
|
|
2023
Q1 | $4.15M | Buy |
450,893
+40,547
| +10% | +$373K | ﹤0.01% | 1027 |
|
|
2022
Q4 | $4.58M | Buy |
410,346
+17,550
| +4% | +$196K | ﹤0.01% | 1022 |
|
|
2022
Q3 | $3.47M | Buy |
392,796
+84,282
| +27% | +$745K | ﹤0.01% | 1046 |
|
|
2022
Q2 | $2.13M | Buy |
308,514
+1,093
| +0.4% | +$7.53K | ﹤0.01% | 1077 |
|
|
2022
Q1 | $3.13M | Buy |
307,421
+52,730
| +21% | +$537K | ﹤0.01% | 1057 |
|
|
2021
Q4 | $2.34M | Buy |
254,691
+5,664
| +2% | +$52.1K | ﹤0.01% | 1165 |
|
|
2021
Q3 | $2.43M | Sell |
249,027
-9,155
| -4% | -$89.2K | ﹤0.01% | 1150 |
|
|
2021
Q2 | $2.56M | Buy |
+258,182
| New | +$2.56M | ﹤0.01% | 1120 |
|